Cargando…
Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases
Colorectal liver metastases (CRLM) are the leading cause of death among patients with metastatic colorectal cancer (CRC). As part of multimodal therapy, liver resection is the mainstay of curative-intent treatment for select patients with CRLM. However, effective treatment of CRLM remains challengin...
Autores principales: | Wong, Geoffrey Yuet Mun, Diakos, Connie, Hugh, Thomas J., Molloy, Mark P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181741/ https://www.ncbi.nlm.nih.gov/pubmed/35682769 http://dx.doi.org/10.3390/ijms23116091 |
Ejemplares similares
-
Prognostic Models Incorporating RAS Mutation to Predict Survival in Patients with Colorectal Liver Metastases: A Narrative Review
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022) -
Recurrence patterns predict survival after resection of colorectal liver metastases
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022) -
Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023) -
A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis
por: Vafaee, Fatemeh, et al.
Publicado: (2018) -
The Role of Biomarkers in the Management of Colorectal Liver Metastases
por: Hewitt, Daniel Brock, et al.
Publicado: (2022)